Archive for the ‘ Industry Analysis ’ Category


by Rob__

State Department: The First Publicly Reported The National Census On Pollution Sources Article Read More

Research Report on China’s insecticide market 2009-2011

style = “float: left; margin: 5px; font-size: 80%”>


Research report on the insecticide market in China, 2009-2011

In 2008, there are no serious insect pests on rice, declined requests to the insecticide market in China from 140,000 tonnes (technical), a decrease of 3.24%. Many manufacturers of insecticides in China had remained low for many products in stock and price.

Read More

style = “float: left; margin: 5px; font-size: 80%”>


Rob__

understanding of the markets of China begins with the right principles

China, China, China. Not a day goes by without a mention of “China” in discussions of the international trading community. It seems to open every company in every industry, he wants the potential. However, the success and profitability in this vast market, we must understand the local dynamics of sound.

How do you reliable information on the market as diverse and the market faster, so you can understand the potential risks and create opportunities and practical strategies? First, start with five main principles.

where to find the information you need. Read More

Fast Food Weight Loss – Is Eating At McDonald’s The New Path To Weight Loss? Read More

The financial management of the supply chain

Financial Supply Chain Management

Supply Chain Financial Management Read More

style = “float: left; margin: 5px; font-size: 80%”>


Rob__

Emissions from the point on the surface : the cause of pollution affecting both censuses

“two sessions” published on the eve of the national census of pollution. Eleventh National Committee of the CPPCC, the State Council, the first national survey of pollution sources have been obtained leading group office abstracts of the “two sessions” during an interview to the press the results of the census source of pollution in China in-depth analysis and interpretation. The differences reflect the state of data Read More

Following 30 years of economic reforms, China has achieved remarkable success in economic development. Now few economists and marketers doubt that China will evolve into a nation of spenders. Along with the rising of income level, the purchasing power of Chinese consumers has been increasing rapidly. Clothing expenditures have also been growing fast. The retail sales of China market in 2007 reached US $ 2970 billion with clothing’s contribution of US $ 150 billion, according to official figures by National Statistics Bureau. Kurt Salmon Associates forecast that by 2020 total clothing consumption of China will be about 120% of that of Japan, from current about 10% of Japan. It is this market perspective that has attracted many overseas investors. Many international clothing manufacturers and retailers are increasingly viewing China as a huge potential marker. Read More

In November 2008, China announced a major economic stimulus package, including $124bn to be spent on healthcare. These changes will have a major impact on the Chinese pharmaceutical landscape over the next 15 years, as the stimulus increases the number of clinics in rural areas, dissociates pharmacies from hospitals and promises healthcare coverage to 100% of the population by 2020. This report – Chinese Pharmaceutical Market Outlook 2009-2024 – analyses prospects for the pharma market and industry sector in China. This new study discusses market drivers and restraints such as production capacity, intellectual property rights and the high, fast-growing healthcare demands in China. Importantly, we provide detailed sales forecasting at the core of the analyses.

As both a large producer and consumer of a wide range of medicines, China is now a crucial player in the global pharmaceutical market and industry. China is still a challenging environment for foreign companies, investors and purchasers. Will the great potential benefits offered by China outweigh its drawbacks as a pharma market? Yes they will – but how and why? Read this report to find out.

China’s rising significance in the global pharma market will make it a vital market for international pharmaceutical companies to enter and expand. China’s efforts to reinvent its healthcare system will change the way pharmaceuticals are marketed and sold throughout the country. However, those changes will not take place immediately. What will happen first? For example, how will prescription of antibiotics change? Also, what impact will reported quality concerns and counterfeiting have on China’s pharmaceutical sector?

Comprehensive analysis of the Chinese pharma sector

Chinese Pharmaceutical Market Outlook 2009-2024 examines that sector critically, through a comprehensive review of information sources. This report provides detailed sales forecasts, discussions of developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 70 tables and figures and a full interview transcript from our survey. The result is a comprehensive market- and industry-centred report, with detailed analyses and informed opinion to benefit your work.

Why you should buy Chinese Pharmaceutical Market Outlook 2009-2024

In this report you will receive the following benefits in particular:• Sales forecasts for the overall Chinese pharma market from 2009 to 2024• Sales forecasts for top-selling drug categories in that market from 2009 to 2024• Comprehensive discussions to support the forecasts, including SWOT analysis and discussions of market drivers and restraints• Forecasts for prescription drugs, branded drugs, generics, over-the-counter treatments and the clinical trials market in China• Expert opinion from our original survey on emerging medical trends in China.

Crucial questions answered by this report:

This report answers important questions such as:• What are the highest-selling drug types in China and how will their sales develop from 2009 onwards?• How will the healthcare stimulus affect sales of diabetes medicines by 2014?• Which companies are investing in China? What types of investments are they making?• What is China’s scientific and technological expertise like?• What domestic pharma companies are making promising developments, and what do their business models suggest about China’s pharma industry?• What does China’s research and development landscape look like for pharma?• Why is China such an important research and development environment for stem cells technologies?• What is the generic drug penetration in China? How will market shares for original-branded and generic drugs change from 2009 onwards?• Why are clinical trials moving to China, and how will that market develop?

You can obtain this report today

China’s pharmaceutical market 2009-2024 Outlook for your company receives the information necessary to understand this dynamic and rapidly growing pharmaceutical market. This report gives you the information you need to evaluate the quantitative and qualitative pharmaceutical market in China in order to understand their likely future behavior, including the legal, social and arenguh & # xE4; ireid complexity. For more information, please contact: http://www. aarkstore. com/reports/Chinese-Pharmaceutical-Market-Outlook-2009-2024-32520. html


Article Source:China Sourcing Blog Read More

On November 24, the first held in guangzhou car than Tokyo motor show. As a local good-famed auto, this also is the first in more than five on the scale of international auto show in Tokyo, domestic car enterprises are confident. Can say, the guangzhou car has the meaning of landmark.

Audience, especially the 2009 China market structure of the year: in 2009, positive support policy, China’s market out of a proud positive line, And in the coming 2010, China’s car more consistent high executives, Chinese market will continue to rise, reached between 10-15%.

Senior automobile industry insiders even assert that can be defined as 2009 second-round growth in China market.

However, both in 2009, by 2010 in 2009, whether is the last point in a busy JiuHanErRe car, now this calm thinking, how to measure not the layout, the future?

To a certain extent, the car is a map, gorgeous, China is behind the industry layout and future market trends.

Guangzhou motor car branch committee secretary, WangXia secretary tells a reporter, “Japan is relatively large financial crisis, many European manufacturers are not in Tokyo motor show, show guangzhou. But manufacturers are almost all fronts. ” WangXia thinks, this mainly because of China’s automobile market performance of huge market potential.

Guangzhou car, as this will start on the eve of one of the big winners in the market, dongfeng nissan RenYong deputy general manager to reporters here hold wine, 2009, we can be defined as a second growth in China market.

Data from 2009, October 20, China’s car sales reached 10 million vehicles in the General Association of Zhongqi Dongyang can think of more than 12 million S & # xF5; idukit.

This reminds one of another Chinese market glorious years – 2003. This year, China has become the world’s fourth-largest automobile market, in December, the world 111. 48% soared to stare. But soon, and in April, car sales began to appear, “negative”, may sit in a blowout immediately after a decline.

That is the second round by industry of China’s market growth in 2009, will be on the scene of similar?

However, capital market, the characteristics of each chakra is won’t repeat the bull market. Market growth. China’s auto big bull market in the round, and the Chinese market since 2003 first-round blowout, many new features.

After the financial crisis, the global automotive market hot from Europe, America and Japan to the traditional market in China, India and other emerging markets.

RenYong tells a reporter, “in fact, the multinational companies in China’s strategy is same, expand. Grab market share. But the reporter discovery, 2009, major automobile company in finance are more robust growth in pursuit, including investment decisions, also said goodbye to the past, blind expansion pouring new factory. Big

China’s President and chief executive of Volkswagen van ender tells a reporter, in this release of 2018 strategy, to the 2018, mass production in China will reach 200 million vehicles. “Further optimization of nanjing and chengdu plant capacity, in order to achieve this goal. ” capacity, But before the market in China, Shanghai Volkswagen heavily to building a new factory, he said, this is just speculation, not confirmed.

Volkswagen Expansion in China, said a fan why the cautious stance, “the current world economy, Shanghai Underwood worst polluters economic lows, but there are still many uncertain factors. It must be ext & # xE4; gene in bone , a market demand, the most comprehensive. Of course, I get to the Chinese market is still in the year 2012 “.

Not only public attitudes conservative, Toyota China gm and Mr. Kato told reporters, “2011 to build a new factory in Shanghai, the first thing, Toyota has no plans, is not fact. About production capacity, currently in the north and the south AnQi respectively faw group and group, in hopes of existing production capacity of ascension based on”.

China’s car market in this round of high growth, finally said goodbye to yield no income “, “the embarrassing situation. According to access for automobile industry researcher securities industry operation index data such as investigation, “by August, China’s automotive industry profit growth more than 10%. If it does not include commercial and spare parts industry, China’s passenger car enterprise’s profit growth is expected to reach year-on-year, 20-30%, the present situation of rapid growth of. ”


Article Source:China Sourcing Blog Read More

Medical Devices Market in China 2009-2013

With the aid of advanced technologies, innovative devices have been introduced in the medical field. These medical devices have been broadly classified as medical disposables, surgical equipment, diagnostic equipment, laboratory devices and diagnostics, dental equipment, and ophthalmic equipment.

After TechNavio, Medical Devices Market in China is expected to $ 25,770. 9 $ 16,677 million in 2013. 0000000 2009, growing at CAGR for 11 years. 5 per cent over the forecast period.

Rapidly growing technology, increasing demand for innovative medical devices together withaging population and prevalence of chronic illness are very important growth drivers for the medical devices market in China. Growing health awareness among consumers and support from government through various initiatives are also very significant factors that drive this market.

The Chinese government is taking many initiatives by investing in healthcare projects to improve the country’s healthcare standards and provide adequate healthcare facilities. The aim is to improve the overall healthcare infrastructure and provide access to the latest medical equipment and facilities. The government also funds the construction of clinics in remote village areas and expansion of health insurance programmes to cover all rural residents. With such a strong government support, the Chinese Medical devices market is poised for a tremendous growth.

Many Medical devices companies are concerned with outsourcing issues such as loss of information, confidentiality, and control over the quality of manufacturing or clinical trials. In addition, companies are also concerned with intellectual property thefts, as the patents become invalid once the manufacturing units move outside the US or Europe. The products are under the risk of design piracy by the local Chinese manufacturers, resulting in massproduction of low-cost devices.

The report by TechNavio Insights forecasts the size of the Medical Devices market in China over the period 2009-2013. Further, it discusses the key market trends, drivers and challenges of this market, and profiles some of the key vendors in the same.

 

 

Â


Article Source:China Sourcing Blog Read More